Clinical trial
RESONATE: A Randomised Controlled Trial of Problem Solving Treatment for Diabetes in Individuals With Poor Diabetes Control
NCT05651490 is registered in ClinicalTrials.gov with Singapore Eye Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- RESONATE: A Randomised Controlled Trial of Problem Solving Treatment for Diabetes in Individuals With Poor Diabetes Control
- Lead sponsor
- Singapore Eye Research Institute
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 9, 2020
- Completion date
- March 31, 2024
- Enrollment
- 106 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.